28,80 €
- Juni
- Juli
- Aug.
- Sept.
- 28.79
- 28.80
ERTRÄGE
Warnung: Die Dividende wurde um 35,1% gekürzt auf 0,02 € pro Aktie. Dies könnte eine strategische Entscheidung sein oder auf veränderte finanzielle Prioritäten hinweisen. Aktionäre sollten prüfen, ob dies ein isolierter Rückschlag oder ein Zeichen struktureller Probleme ist.
0,021 €
Jährliche Dividende
0,073 %
Rendite
-35,08 %
Dividenden-Wachstum
1,49 %
Ausschüttungsquote
UNTERNEHMEN
122,1 Mio. €
Umsatz
2,75 %
Umsatz-Wachstum
19,7 Mio. €
Nettogewinn
-
57,0 %
ROE -
16,1 %
ROS -
15,9 %
ROA -
32,3 %
GPM
22,2 Mio. €
Operativer Cashflow
34,5 Mio. €
Eigenkapital
91
Mitarbeiter
-
1,3 Mio. €
Umsatz / MA -
216.549,5 €
Gewinn / MA
KGV
7,28 €KBV
4,15 €KCV
6,95 €KUV
1,18 €EV/EBITDA
5,06 €EV/EBIT
7,09 €EV/FCF
9,66 €EV/Umsatz
1,63 €EnterpriseValue
199,5 Mio. €Eigenkapitalrendite
57,04 %Umsatzrendite
16,14 %EBIT-Marge
23,06 %EBITDA-Marge
32,30 %Kapitalumschlag
0,98 €Gesamtkapitalrendite
15,89 %Eigenkapitalquote
0,28 €Fremdkapitalquote
0,72 €Verschuldungsgrad
2,59 €Dyn. Verschuldungsgrad
4,03 €Sachinvestitionsquote
-0,004 €Anlagendeckungsgrad 1
1,78 €Anlagendeckungsgrad 2
0,64 €Liquidität 1. Grades
1,18 €Liquidität 2. Grades
1,73 €Liquidität 3. Grades
2,20 €Dividende pro Aktie
0,05 €Dividendenrendite
0,20 %Ausschüttungsquote
1,49 %Buchwert pro Aktie
5,87 €Cashflow pro Aktie
3,77 €Stand: 31.03.2025 TTM
Fakten
-
Sitz
Deutschland
-
Hauptsitz
Gräfelfing
-
Börsengang
19.06.2020
-
Ausstehende Aktien
5,88 Mio.
-
Mitarbeiter
91
-
Währung
EUR
-
Sektor
Gesundheitswesen
-
Industrie
Drug Manufacturers - Specialty & Generic
-
Börse
XETRA
-
Ticker
PSG.DE
-
Webseite
Aktie
Unternehmensinfos
PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.
PharmaSGP Holding SE manufactures over-the-counter drugs, and other healthcare products in Germany. The company's pharmaceutical products include Baldriparan for the treatment of sleep disorders; Spalt, Formigran, and Kamol massage cream for the treatment of different pain conditions; RubaXX pharmaceutical drops for the treatment of rheumatic pain in bones, tendons, and muscles; Restaxil pharmaceutical drops for the treatment of nerve pain in neck and back; Fulminan, a beauty drink for problems in areas, such as eye area, buttocks, or thighs; DESEO pharmaceutical drops for sexual weakness; Neradin, a drug for sexual dysfunction; and TAUMEA, a drug for the treatment of vertigo. It also offers products for the treatment of chronic indications, including pain and other age-related ailments. The company sells its products through pharmacies and wholesalers. It exports its products to European countries comprising Austria, Italy, Belgium, Spain, and France. The company was founded in 2012 and is based in Gräfelfing, Germany.